{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:44:32Z","timestamp":1790790272256,"version":"4.1.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Basic Research and Frontier Exploration Program of Chongqing Scientific and Technological Committee","award":["cstc2018jcyjAX0748"],"award-info":[{"award-number":["cstc2018jcyjAX0748"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>There are approximately 2 billion HBV-infected individuals worldwide, and approximately 1.87% to 7% of these individuals are copositive for HBsAg and HBsAb.<\/jats:p>\n            <jats:p>Our study detected hepatitis B virus pgRNA (HBV RNA) levels in HBsAg and HBsAb copositive patients and then analyzed the correlation with HBV DNA, HBsAg, ALT, and AST levels. A total of 149 HBsAg and HBsAb copositive patients were identified from 66,617 outpatients.<\/jats:p>\n            <jats:p>HBV RNA, HBV DNA, HBsAg, ALT, and AST serum levels were significantly different in different natural phases of HBV infection (immune tolerance phase, immune clearance phase, low replication phase, and reactivation phase) with statistical significance (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.01). HBV RNA levels were positively correlated with HBV DNA, HBsAg, ALT, and AST levels. HBV RNA and HBV DNA levels were significantly increased in the HBeAg-positive group (66 patients) compared with the HBeAg-negative group (83 patients) (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.01). In the HBeAg-positive group, HBV RNA levels were positively correlated with HBV DNA and HBsAg levels. In the HBeAg-negative group, HBV RNA levels were positively correlated with HBV DNA. Serum HBV RNA levels were positively correlated with HBV DNA, HBsAg, ALT, and AST levels.<\/jats:p>\n            <jats:p>HBV RNA could be used as a virological indicator for antiviral therapy in HBsAg and HBsAb copositive hepatitis B patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000027433","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T13:35:32Z","timestamp":1633700132000},"page":"e27433","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Analysis of serum hepatitis B virus RNA levels among HBsAg and HBsAb copositive patients and its correlation with HBV DNA"],"prefix":"10.1097","volume":"100","author":[{"given":"Yu","family":"Xiang","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Jinshan Hospital, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3936-1642","authenticated-orcid":false,"given":"Wenxian","family":"You","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,10,8]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cld.2016.06.006","article-title":"Epidemiology of hepatitis B virus infection and impact of vaccination on disease","volume":"20","author":"Nelson","year":"2016","journal-title":"Clin Liver Dis"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","article-title":"Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity","volume":"30","author":"Ott","year":"2012","journal-title":"Vaccine"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd","year":"2013","journal-title":"Hepatology"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Trepo","year":"2014","journal-title":"Lancet"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/jmv.23779","article-title":"Coexistence of hepatitis B surface antigen and antibody hepatitis B surface may increase the risk of hepatollular carcinoma in chronic hepatitis B virus infection:a retrospective cohort study","volume":"86","author":"Seo","year":"2014","journal-title":"J Med Virol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00705-011-1215-5","article-title":"Coexistence of hepatitis B surface antigen and anti-HBs in Chinese chronic hepatitis B virus patients relating to gentype C and mutations in the S and P gene reverse transcriptase region","volume":"157","author":"Liu","year":"2012","journal-title":"Arch Virol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1086\/513200","article-title":"Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection","volume":"44","author":"Zhang","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.12659\/MSM.905033","article-title":"Patients with coexistence of circulating hepatitis B surface antigen and its antibody may have a strong predisposition to virus reactivation during immunosuppressive therapy: a hypothesis","volume":"23","author":"Chen","year":"2017","journal-title":"Med Sci Monit"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1038\/s41598-019-56015-8","article-title":"Long-term outcomes of HBsAg\/anti-HBs double-positive versus HBsAg single-positive patients with chronic hepatitis B","volume":"9","author":"Kwak","year":"2019","journal-title":"Sci Rep"},{"key":"R10-20250504","first-page":"01","article-title":"Guidelines of prevention and treatment for chronic hepatitis B (2015)","volume":"7","year":"2015","journal-title":"Chin J Hepatol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1093\/jac\/dkr388","article-title":"Nucleoside nucleotide analogues in the treatment of chronic hepatitis B","volume":"66","author":"Fung","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1243462","article-title":"Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA","volume":"343","author":"Lucifora","year":"2014","journal-title":"Science"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"9554","DOI":"10.3748\/wjg.v21.i32.9554","article-title":"Dual gRNAs guided CRISPR\/Cas9 system inhibits hepatitis B virus replication","volume":"21","author":"Wang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/infdis\/jiv397","article-title":"Hepatitis B virus pregenomic RNA is present in virions in plasma and is associated with a response to pegylated interferon alfa-2a and nucleos (t) ide analogues","volume":"213","author":"Jansen","year":"2016","journal-title":"J Infect Dis"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1126\/scitranslmed.aan0241","article-title":"RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg","volume":"9","author":"Wooddell","year":"2017","journal-title":"Sci Transl Med"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2016.05.029","article-title":"Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound","volume":"65","author":"Wang","year":"2016","journal-title":"J Hepatol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1099\/vir.0.80810-0","article-title":"A quasi-monoclonal anti-HBs response can lead immune escape of \u2018wild-type\u2019 hepatitis B virus","volume":"86","author":"Severine","year":"2005","journal-title":"J Gen Virol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/jmv.10267","article-title":"Hepatitis B virus S gene mutants in a patient with chronic active hepatitis with circulating anti-HBs antibodies","volume":"69","author":"Mathet","year":"2003","journal-title":"J Med Virol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1046\/j.1440-1746.2002.02627.x","article-title":"Wild-type and \u2018a\u2019epitope variants in chronic hepatitis B virus carriers positive for hepatitis B surface antigen and antibody","volume":"17","author":"Mesenas","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1128\/JVI.80.6.2968-2975.2006","article-title":"Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of \u201ca\u201d determinant variants","volume":"80","author":"Lada","year":"2006","journal-title":"J Virol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1007\/s00535-012-0737-2","article-title":"Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B infections","volume":"48","author":"Tsuge","year":"2013","journal-title":"J Gastroenterol"},{"key":"R22-20250504","first-page":"197","article-title":"Detectability and clinical significance of serum hepatitis B virus ribonucleic acid","volume":"4","author":"Huang","year":"2015","journal-title":"Hepatobiliary Surg Nutr"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Satin","year":"2016","journal-title":"Hepatol Int"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/hep.510230303","article-title":"Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus","volume":"23","author":"Kock","year":"1996","journal-title":"Hepatology"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/hep.27381","article-title":"Serum hepatitis B virus RNA levels as an early predictor of hepatitis B envelope antigen seroconversion during treatment with polymerase inhibitors","volume":"6l","author":"Van Bommel","year":"2015","journal-title":"Hepatology"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/hep.29872","article-title":"Host and viral factors associated with serum hepatitis B virus RNA levels among patients in need for treatment","volume":"68","author":"Van Campenhout","year":"2018","journal-title":"Hepatology"},{"key":"R30-20250504","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.62079","article-title":"Characterization of serum HBV RNA in patients with untreated HBeAg-positive and-negative chronic hepatitis B infection","volume":"18","author":"Li","year":"2018","journal-title":"Hepatitis Monthly"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/cid\/ciaa013","article-title":"Hepatitis B virus RNA as early predictor for response to pegylated interferon alpha in HBeAg-negative chronic hepatitis B","volume":"72","author":"Farag","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R32-20250504","first-page":"668","article-title":"Value of serum HBV RNA in HBeAg-negative patients with chronic hepatitis B","volume":"27","author":"Jiang","year":"2019","journal-title":"Zhonghua gan zang bing za zhi"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:32:38Z","timestamp":1746340358000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,8]]},"references-count":31,"journal-issue":{"issue":"40","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000027433","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,8]]},"assertion":[{"value":"2021-02-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}